Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01830 |
| Species: | Homo sapiens |
| Position : | chr6:53260000-53270000 |
| Year: | 2025 |
| Title: | Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41016515 |
| MONDO: | |
| Tissue: | Heart |
| Tissue Ontology ID: | UBERON:0000948 |
| Cell Source: | hPSC-CMs |
| CVCL ID: | |
| Cell Type: | cardiomyocyte |
| Cell Ontology ID: | CL:0000746 |
| Experiment Type: | Super-enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, ATAC-seq |
| Low Throughput Method: | Luciferase reporter assay, CRISPRi, RT-RT-qPCR |
| Target gene : | ELOVL5 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|